9-114330476-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000608.4(ORM2):c.157G>A(p.Glu53Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,610,044 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000608.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ORM2 | NM_000608.4 | c.157G>A | p.Glu53Lys | missense_variant | 2/6 | ENST00000431067.4 | NP_000599.1 | |
AKNA | XR_929844.4 | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ORM2 | ENST00000431067.4 | c.157G>A | p.Glu53Lys | missense_variant | 2/6 | 1 | NM_000608.4 | ENSP00000394936 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000801 AC: 12AN: 149878Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000917 AC: 23AN: 250732Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135572
GnomAD4 exome AF: 0.000122 AC: 178AN: 1460166Hom.: 1 Cov.: 32 AF XY: 0.000124 AC XY: 90AN XY: 726500
GnomAD4 genome AF: 0.0000801 AC: 12AN: 149878Hom.: 0 Cov.: 29 AF XY: 0.0000547 AC XY: 4AN XY: 73184
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.157G>A (p.E53K) alteration is located in exon 2 (coding exon 2) of the ORM2 gene. This alteration results from a G to A substitution at nucleotide position 157, causing the glutamic acid (E) at amino acid position 53 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at